Safety and Efficacy Study of Clindamycin/Benzoyl Peroxide/Tazarotene Cream in Subjects With Acne
Public ClinicalTrials.gov record NCT00713609. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multi-center, Randomized, Double-blind, Vehicle-Controlled, Phase 2 Study of the Safety and Efficacy of Benzoyl Peroxide/Clindamycin Gel and Tazarotene Cream When Used in Combination in the Treatment of Acne Vulgaris
Study identification
- NCT ID
- NCT00713609
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Stiefel, a GSK Company
- Industry
- Enrollment
- 591 participants
Conditions and interventions
Conditions
Interventions
- Benzoyl peroxide gel Drug
- Clindamycin gel Drug
- Tazarotene cream Drug
- Vehicle gel Drug
- Vehicle cream Drug
Drug
Eligibility (public fields only)
- Age range
- 12 Years to 45 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 31, 2008
- Primary completion
- Feb 28, 2009
- Completion
- Feb 28, 2009
- Last update posted
- Mar 5, 2017
2008 – 2009
United States locations
- U.S. sites
- 16
- U.S. states
- 11
- U.S. cities
- 16
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Dermatology Research of Arkansas | Little Rock | Arkansas | 72205 | — |
| Center for Dermatology Cosmetic and Laser Surgery | Fremont | California | 94538 | — |
| Center for Dermatology and Laser Surgery | Sacramento | California | 95819 | — |
| Boulder Medical Center, P.C. | Boulder | Colorado | 80304 | — |
| Dermatology Associates Research | Coral Gables | Florida | 33134 | — |
| MedaPhase, Inc. | Newnan | Georgia | 30263 | — |
| Callender Center for Clinical Research | Mitchellville | Maryland | 20721 | — |
| Grekin Skin Institute | Warren | Michigan | 48088 | — |
| University of North Carolina Chapel Hill | Chapel Hill | North Carolina | 27599 | — |
| Dermatology Consulting Services | High Point | North Carolina | 27262 | — |
| MS Hershey Medical Center | Hershey | Pennsylvania | 17033 | — |
| Rivergate Dermatology & Skin Care Center | Goodlettsville | Tennessee | 37072 | — |
| The Skin Wellness Center, PC | Knoxville | Tennessee | 37922 | — |
| Dermatology Treatment & Research Center | Dallas | Texas | 75230 | — |
| Suzanne Bruce and Associates, PA | Houston | Texas | 77056 | — |
| Dermatology Clinical Research Center of San Antonio | San Antonio | Texas | 78229 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00713609, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 5, 2017 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00713609 live on ClinicalTrials.gov.